Search Within

Sloan Kettering Institute Postdocs

Formats
  1. Journal Article (8036)
  2. Meeting Abstract (3693)
  3. Review (630)
  4. Editorial (262)
  5. Book Section (195)
  6. Conference Paper (161)
  7. Research Letter (139)
  8. Correspondence (68)
  9. Miscellaneous (67)
  10. Guidelines (30)
  11. Book Whole (6)
Groups
  1. GSK Faculty (6363)
  2. Department of Medicine (4809)
  3. Sloan Kettering Institute Faculty (3570)
  4. Center for Molecular Imaging and Biotechnology (CMIB) (3037)
  5. Surgery (2633)
  6. Solid Tumor Oncology Division (2604)

More Groups

People
  1. Britta Weigelt (376)
  2. Jorge Reis-Filho (328)
  3. Mithat Gonen (318)
  4. Marc Ladanyi (309)
  5. Michael Berger (288)
  6. Joseph Deasy (285)

More People

Years
  1. 2026 (1)
  2. 2025 (697)
  3. 2024 (1080)
  4. 2023 (1152)
  5. 2022 (1366)
  6. 2021 (1179)

More Years

Publications
  1. Blood (680)
  2. Cancer Research (543)
  3. Journal of Clinical Oncology (431)
  4. Journal of Nuclear Medicine (271)
  5. Annals of Surgical Oncology (264)
  6. Clinical Cancer Research (249)

More Publications

Publishers
  1. Nature Publishing Group (1349)
  2. Elsevier Inc. (1106)
  3. American Association for Cancer Research (1058)
  4. Springer (840)
  5. American Society of Hematology (740)
  6. Cell Press (740)

More Publishers

Results (13287)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Mechanisms of mTORC1 activation by RHEB and inhibition by PRAS40
    Journal Article

    Yang, H.; Jiang, X.; Li, B.; Yang, H. J.; Miller, M.; Yang, A.; Dhar, A.; Pavletich, N. P.
    Nature (2017)

    Fulltext@MSK | Save
  • Malignant transformation of glucagonoma with SPECT/CT In-111 OctreoScan features: A case report
    Journal Article

    Corrias, G.; Horvat, N.; Monti, S.; Basturk, O.; Lin, O.; Saba, L.; Bodei, L.; Reidy, D. L.; Mannelli, L.
    Medicine (2017)

    Fulltext@MSK | Save
  • Comparative study of the clinical, histological, and biological characteristics of squamous cell carcinomas in areas previously treated with photodynamic therapy
    Journal Article

    Gracia Cazaña, T.; Salazar, N.; Vera-Álvarez, J.; González, S.; Juarranz, A.; Gilaberte, Y.
    European Journal of Dermatology (2017)

    Fulltext@MSK | Save
  • Statistical learning as a domain-general mechanism of entrenchment
    Book Section

    Jost, E.; Christiansen, M. H.
    In Schmid, H. J. (Eds.) Entrenchment and the Psychology of Language Learning: How We Reorganize and Adapt Linguistic Knowledge (2017)

    Fulltext@MSK | Save
  • Day 0 dosimetric evaluation for LDR prostate brachytherapy may be superior to day 30 assessments by providing similar quality assurance information at earlier time points
    Meeting Abstract

    King, M. T.; Cohen, G. N.; Kollmeier, M. A.; Pei, X.; Damato, A. L.; Zelefsky, M. J.
    Brachytherapy (2017)

    Fulltext@MSK | Save
  • PIK3 mutations are associated with decreased local control in brain metastases treated with radiation
    Meeting Abstract

    Lockney, N.; Wang, D.; Lin, A.; Pei, X.; Chan, T.; Yamada, Y.; Beal, K.; Yang, T. J.
    Neuro-Oncology (2017)

    Fulltext@MSK | Save
  • Value of T2-weighted MR imaging to evaluate drug distribution the brain stem of children
    Meeting Abstract

    Wembacher-Schroeder, E.; Zhou, Z.; Pandit-Tasker, N.; Souweidane, M. M.
    Neuro-Oncology (2017)

    Fulltext@MSK | Save
  • A pilot study of cognitive functions, APOE and amyloid imaging in glioma patients
    Meeting Abstract

    Correa, D.; Kryza-Lacombe, M.; Zhou, X.; Baser, R.; Beattie, B.; Beiene, Z.; Humm, J.; DeAngelis, L.; Orlow, I.; Weber, W.; more...
    Neuro-Oncology (2017)

    Fulltext@MSK | Save
  • Robust patient-derived xenografts (PDX) capture the disease fidelity of chronic myelomonocytic leukemia (CMML) and juvenile myelomonocytic leukemia (JMML)
    Meeting Abstract

    Balasis, M. E.; Yoshimi, A.; Vedder, A.; Feldman, K.; Ma, Y.; Zhang, H.; Lee, S. C. W.; Letson, C.; Niyongere, S.; Lu, S. X.; more...
    Leukemia Research (2017)

    Fulltext@MSK | Save
  • Immunotherapy for KRAS positive lung adenocarcinoma: Mesothelin and CA125 (MUC16) are cancer-antigen targets
    Meeting Abstract

    Hristov, B.; Eguchi, T.; Chintala, N.; Lu, S.; Bott, M.; Travis, W.; Jones, D.; Adusumilli, P.
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save